Francesc Bosch
- 専門分野: Hematologist
- 126年の経験
- 話します:English, Spanish
- オンラインコンサルテーション：利用可能
- 勤務先: スペイン, バルセロナ, Hospital Quiron Barcelona
- Hematology Unit, IOB Institute of Oncology Head of Haematology Unit, Vall d’Hebron Hospital
Dr. Francesc Bosch is an expert in Chronic Lymphocytic Leukemia (CLL) and lymphomas. He leads research in the molecular causes and new treatments for CLL and other lymphoproliferative disorders.
He has published over 100 articles in leading journals, including The New England Journal of Medicine and Nature Medicine. Dr. Bosch oversees more than 80 clinical studies, from phase 1 to phase 3, and plays a key role in developing new drugs.
He is the Head of Hematology at Vall d’Hebron University Hospital and IOB Institute of Oncology. He also serves as president of GELLC and is a professor of hematology. His work has improved diagnosis and treatment for blood diseases.
Francesc Boschとのオンラインコンサルテーション
患者様レビュー
医師のサービス
調子はいかがですか？
資格
A specialist in lymphomas and chronic lymphocytic leukemia, he has, together with his team, achieved innovations in new technologies for the analysis of hematological diseases and new treatments for this type of disease.
Professor Bosch is one of the world’s most highly reputed leaders in Chronic Lymphocytic Leukemia (CLL) and conducts both clinical and basic research on CLL and other lymphoproliferative disorders, focusing especially on the molecular pathogenesis of CLL and the development of new therapeutic approaches.
Professor Bosch is currently working on more than 80 studies from phase 1 to phase 3, which means that new drugs and indications will be available in coming years thanks to research done by Professor Bosch.
Education
- Graduated from the Faculty of Medicine of the University of Barcelona in 1988.
- PhD at the University of Barcelona in 1997 for his research on cyclin D1 overexpression in chronic lymphoproliferative disorders, under the supervision of Professor Elías Campo.
- Two-year post-doctoral fellowship in the laboratory of Professor Riccardo Dalla-Favera at the Institute of Cancer Genetics at Columbia University, New York.
- Investigator into Chronic Lymphocytic Leukemia (LLC) at the Hospital Clínic de Barcelona in 2000.
Career
- President of the Spanish group for the study of chronic lymphocytic leukemia (GELLC) and he leads the clinical trials area.
- Involved since 1995 in the development of clinical trials on CLL, making several contributions to the evaluation of CLL prognosis and treatment.
- Head of Hematology at the IOB Institute of Oncology since 2004.
- Head of the Haematology Department and director of the Laboratory of Experimental Haematology at Barcelona’s Vall d’Hebron University Hospital since 2009.
Publications
- Responsible for publishing more than 100 articles in prestigious scientific journals such as The New England Journal of Medicine, Nature Medicine, Cancer Cell, Blood, Journal of Clinical Oncology, and Leukemia.
- Author and co-author of several reviews and book chapters on CLL and other lymphoproliferative disorders.
Teaching
Professor of Haematology at the Vall d’Hebron University Hospital of Barcelona.
こちらもご興味をお持ちいただけるかもしれません
支払い・特典
当社サービスへのお支払いはありません
クリニックで直接またはその公式銀行口座にお支払いいただきます。
一部のクリニックでは保証金が必要な場合があります。
分割払いオプションでお支払いを分散してください。
Bookimedにお友達を紹介して報酬を獲得してください。